Shattuck Labs Inc

NASDAQ:STTK USA Biotechnology
Market Cap
$376.52 Million
Market Cap Rank
#15217 Global
#6015 in USA
Share Price
$5.95
Change (1 day)
-1.16%
52-Week Range
$0.73 - $6.13
All Time High
$57.61
About

Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company's lead product candidate includes SL-325, a DR3 blocking monoclonal antibody, which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of inf… Read more

Shattuck Labs Inc (STTK) - Total Liabilities

Latest total liabilities as of September 2025: $7.09 Million USD

Based on the latest financial reports, Shattuck Labs Inc (STTK) has total liabilities worth $7.09 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shattuck Labs Inc - Total Liabilities Trend (2018–2024)

This chart illustrates how Shattuck Labs Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Shattuck Labs Inc Competitors by Total Liabilities

The table below lists competitors of Shattuck Labs Inc ranked by their total liabilities.

Liability Composition Analysis (2018–2024)

This chart breaks down Shattuck Labs Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 17.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.07 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shattuck Labs Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shattuck Labs Inc (2018–2024)

The table below shows the annual total liabilities of Shattuck Labs Inc from 2018 to 2024.

Year Total Liabilities Change
2024-12-31 $11.42 Million -23.12%
2023-12-31 $14.86 Million -49.06%
2022-12-31 $29.17 Million +8.84%
2021-12-31 $26.80 Million -31.51%
2020-12-31 $39.13 Million -50.79%
2019-12-31 $79.52 Million +0.35%
2018-12-31 $79.24 Million --